Brooks Laboratories vs Nifty 50: Share Price Performance Compared
- September 10, 2026
- Posted by: Harsh Piplani
- Category: Market
Brooks Laboratories share price Rs 64.68 on NSE. Brooks Laboratories vs Nifty 50 over 1 year: -57.26% vs -6.13%. 52-week high Rs 163.90, low Rs 36.30.
Quick Answer
Brooks Laboratories vs Nifty 50 shows Brooks Laboratories trailing the benchmark on a one-year view, with a return of -57.26% against the Nifty 50’s -6.13%. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock. Investors comparing the two should also weigh Brooks Laboratories’s trading liquidity, valuation and sector context rather than relying on returns alone.
Brooks Laboratories vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Brooks Laboratories trades on the NSE under the symbol BROOKS, and its 1M return of +7.98% compares with the Nifty 50’s -4.65% over the same period.
The Brooks Laboratories vs Nifty 50 comparison matters because Brooks Laboratories is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Brooks Laboratories share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, using NSE closing data.
Click Here – Get Free Investment Predictions
Brooks Laboratories vs Nifty 50: Performance at a Glance
The table below sets out Brooks Laboratories vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 10 September 2026.
| Time Frame | Brooks Laboratories Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | +7.98% | -4.65% | +12.63% pp |
| 3 Months | -4.52% | +0.97% | -5.49% pp |
| 6 Months | +3.54% | -3.38% | +6.92% pp |
| 1 Year | -57.26% (Brooks Laboratories) | -6.13% (Nifty 50) | -51.12% pp |
On the Brooks Laboratories vs Nifty 50 scorecard, Brooks Laboratories has lagged the index over the most recent one-year window. With limited comparable trading history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock.
Check the Univest Screener for live Brooks Laboratories and Nifty 50 data
Why the Brooks Laboratories vs Nifty 50 Gap Exists
Brooks Laboratories’s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Brooks Laboratories vs Nifty 50 return table above.
A second factor behind the Brooks Laboratories vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Brooks Laboratories’s price sharply in either direction over short periods, while the Nifty 50’s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock’s swings.
Download the Univest iOS App or Univest Android App to track Brooks Laboratories and Nifty 50 live on the go.
Brooks Laboratories vs Nifty 50: Has Brooks Laboratories Beaten the Benchmark?
Brooks Laboratories has not kept pace with the Nifty 50 over the past year, posting a return of -57.26% against the index’s -6.13% over the same period.
Risks of the Brooks Laboratories vs Nifty 50 Comparison
Reading too much into a Brooks Laboratories vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Brooks Laboratories carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50’s more liquid, blended profile. A stock’s 52-week range of Rs 36.30 to Rs 163.90 also shows the kind of volatility that a single-stock investment carries relative to a broad index.
Conclusion
Brooks Laboratories vs Nifty 50 highlights how a single stock’s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Brooks Laboratories vs Nifty 50 record should factor in Brooks Laboratories’s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Brooks Laboratories outperformed the Nifty 50 in the last year?
Ans. No. Brooks Laboratories returned -57.26% over the past year while the Nifty 50 returned -6.13% over the same period, based on NSE closing prices to 10 September 2026.
What is the Brooks Laboratories share price today compared to Nifty 50?
Ans. Brooks Laboratories share price stood at Rs 64.68 on NSE, while the Nifty 50 traded at 23,441.20 based on the same closing data window.
What is the 52-week high and low of Brooks Laboratories?
Ans. Brooks Laboratories’s 52-week high is Rs 163.90 and its 52-week low is Rs 36.30, based on NSE data.
Why does Brooks Laboratories show bigger price swings than the Nifty 50?
Ans. Brooks Laboratories carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Brooks Laboratories’s price more sharply than the diversified index, a key reason the Brooks Laboratories vs Nifty 50 return gap varies across time frames.
Is Brooks Laboratories a good long-term investment compared to a Nifty 50 index fund?
Ans. Brooks Laboratories’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Brooks Laboratories vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.
